{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:42:53Z","timestamp":1791290573142,"version":"4.3.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40121-025-01298-w","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:14:00Z","timestamp":1769609640000},"page":"769-785","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj\/Umrah Pilgrims Aged\u2009\u2265\u200956 Years: A Phase\u00a0III, Open-Label Study"],"prefix":"10.1007","volume":"15","author":[{"given":"Ghassan S.","family":"Dbaibo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Balik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130rem","family":"Akdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turan","family":"Buzgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahmet","family":"Guner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina F.","family":"Boutros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Damaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab El","family":"Zein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Merhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawthar","family":"Faour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim","family":"Tfaily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Khafaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alp","family":"Dogu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Ceyhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"issue":"2","key":"1298_CR1","doi-asserted-by":"publisher","first-page":"B3","DOI":"10.1016\/j.vaccine.2011.12.062","volume":"30","author":"D Pace","year":"2012","unstructured":"Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine. 2012;30(2):B3-9. https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.062.","journal-title":"Vaccine"},{"key":"1298_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-61779-346-2_1","volume":"799","author":"NG Rouphael","year":"2012","unstructured":"Rouphael NG, Stephens DS. Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol Biol. 2012;799:1\u201320. https:\/\/doi.org\/10.1007\/978-1-61779-346-2_1.","journal-title":"Methods Mol Biol"},{"key":"1298_CR3","unstructured":"Mbaeyi S, Duffy J, McNamara LA. Meningococcal disease. In: Hall E, Wodi AP, Hamborsky J, Morelli V, Schillie S, editors. Epidemiology and prevention of vaccine-preventable diseases. 14th ed. Washington (DC): CDC; 2021."},{"issue":"5","key":"1298_CR4","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jinf.2020.07.025","volume":"81","author":"AMM Aye","year":"2020","unstructured":"Aye AMM, Bai X, Borrow R, et al. Meningococcal disease surveillance in the Asia-Pacific region (2020): the global meningococcal initiative. J Infect. 2020;81(5):698\u2013711. https:\/\/doi.org\/10.1016\/j.jinf.2020.07.025.","journal-title":"J Infect"},{"issue":"2","key":"1298_CR5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1080\/21645515.2018.1532248","volume":"15","author":"R Booy","year":"2019","unstructured":"Booy R, Gentile A, Nissen M, Whelan J, Abitbol V. Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies. Hum Vaccin Immunother. 2019;15(2):470\u201380. https:\/\/doi.org\/10.1080\/21645515.2018.1532248.","journal-title":"Hum Vaccin Immunother"},{"key":"1298_CR6","unstructured":"Fact Sheet - Meningitis. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/meningitis. Accessed May\u00a015 2025."},{"issue":"16","key":"1298_CR7","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1016\/j.vaccine.2017.03.007","volume":"35","author":"R Whittaker","year":"2017","unstructured":"Whittaker R, Dias JG, Ramliden M, et al. The epidemiology of invasive meningococcal disease in EU\/EEA countries, 2004\u20132014. Vaccine. 2017;35(16):2034\u201341. https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.007.","journal-title":"Vaccine"},{"issue":"2 Suppl","key":"1298_CR8","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jadohealth.2016.04.012","volume":"59","author":"SI Pelton","year":"2016","unstructured":"Pelton SI. The global evolution of meningococcal epidemiology following the introduction of meningococcal vaccines. J Adolesc Health. 2016;59(2 Suppl):S3-S11. https:\/\/doi.org\/10.1016\/j.jadohealth.2016.04.012.","journal-title":"J Adolesc Health"},{"issue":"4","key":"1298_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/14760584.2017.1258308","volume":"16","author":"R Borrow","year":"2017","unstructured":"Borrow R, Alarc\u00f3n P, Carlos J, et al. The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection. Expert Rev Vaccines. 2017;16(4):313\u201328. https:\/\/doi.org\/10.1080\/14760584.2017.1258308.","journal-title":"Expert Rev Vaccines"},{"key":"1298_CR10","unstructured":"Enhanced Meningococcal Disease Surveillance Report. https:\/\/www.cdc.gov\/meningococcal\/media\/pdfs\/2025\/04\/NCIRD-EMDS-Report-2023_508.pdf. Accessed May\u00a015 2025."},{"issue":"8","key":"1298_CR11","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/cid\/cix993","volume":"66","author":"JR MacNeil","year":"2018","unstructured":"MacNeil JR, Blain AE, Wang X, Cohn AC. Current epidemiology and trends in meningococcal disease-United States, 1996-2015. Clin Infect Dis. 2018;66(8):1276\u201381. https:\/\/doi.org\/10.1093\/cid\/cix993.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1298_CR12","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.09.010409","volume":"9","author":"ME Peterson","year":"2019","unstructured":"Peterson ME, Li Y, Bita A, et al. Meningococcal serogroups and surveillance: a systematic review and survey. J Glob Health. 2019;9(1):010409. https:\/\/doi.org\/10.7189\/jogh.09.010409.","journal-title":"J Glob Health"},{"key":"1298_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tmaid.2018.05.003","volume":"24","author":"S Yezli","year":"2018","unstructured":"Yezli S. The threat of meningococcal disease during the Hajj and Umrah mass gatherings: a comprehensive review. Travel Med Infect Dis. 2018;24:51\u20138. https:\/\/doi.org\/10.1016\/j.tmaid.2018.05.003.","journal-title":"Travel Med Infect Dis"},{"issue":"9248","key":"1298_CR14","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/s0140-6736(00)03502-9","volume":"356","author":"MK Taha","year":"2000","unstructured":"Taha MK, Achtman M, Alonso JM, et al. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet. 2000;356(9248):2159. https:\/\/doi.org\/10.1016\/s0140-6736(00)03502-9.","journal-title":"Lancet"},{"key":"1298_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijid.2016.04.007","volume":"47","author":"S Yezli","year":"2016","unstructured":"Yezli S, Assiri AM, Alhakeem RF, Turkistani AM, Alotaibi B. Meningococcal disease during the Hajj and Umrah mass gatherings. Int J Infect Dis. 2016;47:60\u20134. https:\/\/doi.org\/10.1016\/j.ijid.2016.04.007.","journal-title":"Int J Infect Dis"},{"issue":"9934","key":"1298_CR16","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/s0140-6736(14)60381-0","volume":"383","author":"ZA Memish","year":"2014","unstructured":"Memish ZA, Zumla A, Alhakeem RF, et al. Hajj: infectious disease surveillance and control. Lancet. 2014;383(9934):2073\u201382. https:\/\/doi.org\/10.1016\/s0140-6736(14)60381-0.","journal-title":"Lancet"},{"key":"1298_CR17","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.2147\/idr.S375096","volume":"15","author":"S Yezli","year":"2022","unstructured":"Yezli S, Yassin Y, Mushi A, Bukhari M, Banasser T, Khan A. Carriage of Neisseria meningitidis among Umrah pilgrims: circulating serogroups and antibiotic resistance. Infect Drug Resist. 2022;15:4685\u201396. https:\/\/doi.org\/10.2147\/idr.S375096.","journal-title":"Infect Drug Resist"},{"issue":"8","key":"1298_CR18","doi-asserted-by":"publisher","first-page":"868","DOI":"10.15537\/smj.2017.8.20124","volume":"38","author":"S Yezli","year":"2017","unstructured":"Yezli S, Yassin Y, Awam A, Attar A, Al-Jahdali E, Alotaibi B. Umrah. An opportunity for mass gatherings health research. Saudi Med J. 2017;38(8):868\u201371. https:\/\/doi.org\/10.15537\/smj.2017.8.20124.","journal-title":"Saudi Med J"},{"issue":"2","key":"1298_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/s0924-8579(02)00364-3","volume":"21","author":"ZA Memish","year":"2003","unstructured":"Memish ZA, Venkatesh S, Ahmed QA. Travel epidemiology: the Saudi perspective. Int J Antimicrob Agents. 2003;21(2):96\u2013101. https:\/\/doi.org\/10.1016\/s0924-8579(02)00364-3.","journal-title":"Int J Antimicrob Agents"},{"key":"1298_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijid.2015.12.010","volume":"47","author":"S Yezli","year":"2016","unstructured":"Yezli S, Bin Saeed AA, Assiri AM, et al. Prevention of meningococcal disease during the Hajj and Umrah mass gatherings: past and current measures and future prospects. Int J Infect Dis. 2016;47:71\u20138. https:\/\/doi.org\/10.1016\/j.ijid.2015.12.010.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"1298_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106558","volume":"91","author":"J Lucidarme","year":"2025","unstructured":"Lucidarme J, Deghmane AE, Sharma S, et al. Umrah- and travel-associated meningococcal disease due to multiple serogroup W ST-11 sub-strains pre-Hajj 2024. J Infect. 2025;91(4):106558. https:\/\/doi.org\/10.1016\/j.jinf.2025.106558.","journal-title":"J Infect"},{"issue":"22","key":"1298_CR22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.15585\/MMWR.MM7322E1","volume":"73","author":"MS Vachon","year":"2024","unstructured":"Vachon MS, Barret AS, Lucidarme J, et al. Cases of Meningococcal Disease Associated with Travel to Saudi Arabia for Umrah Pilgrimage \u2014 United States, United Kingdom, and France, 2024. MMWR Morb Mortal Wkly Rep. 2024;73(22):514\u20136. https:\/\/doi.org\/10.15585\/MMWR.MM7322E1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"1298_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2025.102728","volume":"18","author":"C Meilleur","year":"2025","unstructured":"Meilleur C, Kus J, Navarro C, et al. Genetically distinct Hajj and South American-related strains of serogroup W Neisseria meningitidis causing invasive meningococcal disease in Ontario, Canada, January 1, 2015 to June 30, 2024. J Infect Public Health. 2025;18(5):102728. https:\/\/doi.org\/10.1016\/j.jiph.2025.102728.","journal-title":"J Infect Public Health"},{"key":"1298_CR24","unstructured":"ECDC Weekly Bulletin Communicable Disease Threat Report Week\u00a024. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/communicable-disease-threats-report-week-24-2024.pdf. Accessed Dec 15 2025."},{"key":"1298_CR25","unstructured":"Disease Outbreak News: Invasive meningococcal disease - Kingdom of Saudi Arabia. https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON563. Accessed Dec 15 2025."},{"key":"1298_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mgmed.2025.100019","volume":"3","author":"NZ Alshahrani","year":"2025","unstructured":"Alshahrani NZ, Rashid H, Parker S, Asiri AM, Memish ZA. Pilgrimage and prevention: closing meningococcal gaps ahead of Hajj 2025. Mass Gather Med. 2025;3:100019. https:\/\/doi.org\/10.1016\/j.mgmed.2025.100019.","journal-title":"Mass Gather Med"},{"key":"1298_CR27","doi-asserted-by":"publisher","unstructured":"Neri A, Taviani E, Ferraro F, et al. Genomic analysis of Neisseria meningitidis serogroup W causing invasive meningococcal disease in four travellers from Saudi Arabia, Italy, 2025. Euro Surveill. 2025;30(31). https:\/\/doi.org\/10.2807\/1560-7917.Es.2025.30.31.2500483.","DOI":"10.2807\/1560-7917.Es.2025.30.31.2500483"},{"issue":"8","key":"1298_CR28","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/s12098-025-05612-9","volume":"92","author":"R Padur Sivaraman","year":"2025","unstructured":"Padur Sivaraman R, Antony T, Manickavel P, Ram L, Muthukumarasamy P. Meningococcal sepsis in close family contact of Umrah pilgrim to Mecca despite pre-travel meningococcal vaccination. Indian J Pediatr. 2025;92(8):880. https:\/\/doi.org\/10.1007\/s12098-025-05612-9.","journal-title":"Indian J Pediatr"},{"issue":"11","key":"1298_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2025.102945","volume":"18","author":"F Ben Abid","year":"2025","unstructured":"Ben Abid F, Ittaman AV, Ibrahim EB, et al. Serogroup W invasive meningococcal disease outbreak in Qatar following travel to Umrah. J Infect Public Health. 2025;18(11):102945. https:\/\/doi.org\/10.1016\/j.jiph.2025.102945.","journal-title":"J Infect Public Health"},{"key":"1298_CR30","unstructured":"Meningococcal vaccines: WHO position paper - November 2011. 2011;47(86):521\u201340. https:\/\/iris.who.int\/bitstream\/handle\/10665\/241846\/WER8647_521-539.PDF?sequence=1. Accessed May\u00a015, 2025."},{"issue":"4","key":"1298_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2991\/jegh.k.200411.001","volume":"10","author":"R Rustika","year":"2020","unstructured":"Rustika R, Oemiati R, Asyary A, Rachmawati T. An evaluation of health policy implementation for Hajj pilgrims in Indonesia. J Epidemiol Glob Health. 2020;10(4):263\u20138. https:\/\/doi.org\/10.2991\/jegh.k.200411.001.","journal-title":"J Epidemiol Glob Health"},{"issue":"28","key":"1298_CR32","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1016\/j.vaccine.2020.04.067","volume":"38","author":"A Esteves-Jaramillo","year":"2020","unstructured":"Esteves-Jaramillo A, Koehler T, Jeanfreau R, Neveu D, Jordanov E, Singh Dhingra M. Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in \u226556-year-olds: a phase\u00a0III randomized study. Vaccine. 2020;38(28):4405\u201311. https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.067.","journal-title":"Vaccine"},{"issue":"1","key":"1298_CR33","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s12889-022-12795-9","volume":"22","author":"S Guedes","year":"2022","unstructured":"Guedes S, Bertrand-Gerentes I, Evans K, Coste F, Oster P. Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature. BMC Public Health. 2022;22(1):380. https:\/\/doi.org\/10.1186\/s12889-022-12795-9.","journal-title":"BMC Public Health"},{"issue":"1","key":"1298_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/23744235.2021.1971289","volume":"54","author":"AE Deghmane","year":"2022","unstructured":"Deghmane AE, Taha S, Taha MK. Global epidemiology and changing clinical presentations of invasive meningococcal disease: a narrative review. Infect Dis Lond. 2022;54(1):1\u20137. https:\/\/doi.org\/10.1080\/23744235.2021.1971289.","journal-title":"Infect Dis Lond"},{"issue":"2","key":"1298_CR35","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jinf.2019.11.001","volume":"80","author":"H Campbell","year":"2020","unstructured":"Campbell H, Andrews N, Parikh S, et al. Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England. J Infect. 2020;80(2):182\u20139. https:\/\/doi.org\/10.1016\/j.jinf.2019.11.001.","journal-title":"J Infect"},{"key":"1298_CR36","doi-asserted-by":"publisher","DOI":"10.1017\/s0950268821001035","volume":"149","author":"O S\u00e4ll","year":"2021","unstructured":"S\u00e4ll O, Stenmark B, Jacobsson S, et al. Atypical presentation of Neisseria meningitidis serogroup W disease is associated with the introduction of the 2013 strain. Epidemiol Infect. 2021;149:e126. https:\/\/doi.org\/10.1017\/s0950268821001035.","journal-title":"Epidemiol Infect"},{"key":"1298_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9287121","volume":"2019","author":"G de Trzewikoswki Lima","year":"2019","unstructured":"de Trzewikoswki Lima G, De Gaspari E. Study of the immune response in the elderly: is it necessary to develop a vaccine against Neisseria meningitidis for the aged? J Aging Res. 2019;2019:9287121. https:\/\/doi.org\/10.1155\/2019\/9287121.","journal-title":"J Aging Res"},{"issue":"6","key":"1298_CR38","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.4161\/hv.24696","volume":"9","author":"JM Lord","year":"2013","unstructured":"Lord JM. The effect of aging of the immune system on vaccination responses. Hum Vaccin Immunother. 2013;9(6):1364\u20137. https:\/\/doi.org\/10.4161\/hv.24696.","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"1298_CR39","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1080\/21645515.2020.1733868","volume":"16","author":"J Kirstein","year":"2020","unstructured":"Kirstein J, Pina M, Pan J, Jordanov E, Dhingra MS. Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56\u00a0years of age and older: a phase\u00a0II randomized study. Hum Vaccin Immunother. 2020;16(6):1299\u2013305. https:\/\/doi.org\/10.1080\/21645515.2020.1733868.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"1298_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2160600","volume":"19","author":"CA Robertson","year":"2023","unstructured":"Robertson CA, Jacqmein J, Selmani A, Galarza K, Oster P. Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged \u226559\u00a0years: a phase\u00a0III randomized study. Hum Vaccin Immunother. 2023;19(1):2160600. https:\/\/doi.org\/10.1080\/21645515.2022.2160600.","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"1298_CR41","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s40266-013-0065-0","volume":"30","author":"G Dbaibo","year":"2013","unstructured":"Dbaibo G, El-Ayoubi N, Ghanem S, et al. Immunogenicity and safety of a quadrivalent meningococcal serogroups\u00a0A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) administered to adults aged 56\u00a0years and older: results of an open-label, randomized, controlled trial. Drugs Aging. 2013;30(5):309\u201319. https:\/\/doi.org\/10.1007\/s40266-013-0065-0.","journal-title":"Drugs Aging"},{"key":"1298_CR42","doi-asserted-by":"publisher","unstructured":"Abstracts of the 19th Congress of the European Geriatric Medicine Society. European Geriatric Medicine. 2023;14(1):1\u2013387. https:\/\/doi.org\/10.1007\/s41999-023-00883-x.","DOI":"10.1007\/s41999-023-00883-x"},{"key":"1298_CR43","doi-asserted-by":"publisher","unstructured":"Maslanka SE, Gheesling LL, Libutti DE, et al. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup\u00a0A and C serum bactericidal assays. The Multilaboratory Study Group. Clin Diagn Lab Immunol. 1997;4(2):156\u201367. https:\/\/doi.org\/10.1128\/cdli.4.2.156-167.1997.","DOI":"10.1128\/cdli.4.2.156-167.1997"},{"issue":"8","key":"1298_CR44","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1128\/cvi.05028-11","volume":"18","author":"PA Mak","year":"2011","unstructured":"Mak PA, Santos GF, Masterman KA, et al. Development of an automated, high-throughput bactericidal assay that measures cellular respiration as a survival readout for Neisseria meningitidis. Clin Vaccine Immunol. 2011;18(8):1252\u201360. https:\/\/doi.org\/10.1128\/cvi.05028-11.","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"1298_CR45","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1007\/s40121-021-00530-7","volume":"10","author":"K Varghese","year":"2021","unstructured":"Varghese K, Bartlett W, Zheng L, et al. A new electrochemiluminescence-based multiplex assay for the assessment of human antibody responses to Bordetella pertussis vaccines. Infect Dis Ther. 2021;10(4):2539\u201361. https:\/\/doi.org\/10.1007\/s40121-021-00530-7.","journal-title":"Infect Dis Ther"},{"issue":"10","key":"1298_CR46","doi-asserted-by":"publisher","first-page":"e868","DOI":"10.1016\/j.ijid.2010.03.017","volume":"14","author":"D Stamboulian","year":"2010","unstructured":"Stamboulian D, Lopardo G, Lopez P, et al. Safety and immunogenicity of an investigational quadrivalent meningococcal CRM(197) conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America. Int J Infect Dis. 2010;14(10):e868\u201375. https:\/\/doi.org\/10.1016\/j.ijid.2010.03.017.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"1298_CR47","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2426868","volume":"20","author":"CA Robertson","year":"2024","unstructured":"Robertson CA, Jacqmein J, Selmani A, Galarza K, Oster P. Immune persistence and booster response of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) 5\u00a0years after primary vaccination of adults at \u226556\u00a0years of age. Hum Vaccin Immunother. 2024;20(1):2426868. https:\/\/doi.org\/10.1080\/21645515.2024.2426868.","journal-title":"Hum Vaccin Immunother"},{"key":"1298_CR48","unstructured":"Health Requirements and Recommendations for Travelers to Saudi Arabia for Hajj. https:\/\/www.moh.gov.sa\/HealthAwareness\/Pilgrims-Health\/Documents\/Hajj-Health-Requirements-English-language.pdf. Accessed Sept 19 2025."},{"issue":"1","key":"1298_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2021.1902701","volume":"18","author":"FM Piazza","year":"2022","unstructured":"Piazza FM, Virta M, Paassilta M, et al. Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3\u00a0years earlier as toddlers: a phase\u00a0III, open-label, multi-center study. Hum Vaccin Immunother. 2022;18(1):1\u201310. https:\/\/doi.org\/10.1080\/21645515.2021.1902701.","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"1298_CR50","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1080\/21645515.2020.1733869","volume":"16","author":"T Vesikari","year":"2020","unstructured":"Vesikari T, Borrow R, Forsten A, Findlow H, Dhingra MS, Jordanov E. Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a phase\u00a0II randomized study. Hum Vaccin Immunother. 2020;16(6):1306\u201312. https:\/\/doi.org\/10.1080\/21645515.2020.1733869.","journal-title":"Hum Vaccin Immunother"},{"issue":"25","key":"1298_CR51","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1016\/j.vaccine.2017.04.078","volume":"35","author":"M Br\u00f6ker","year":"2017","unstructured":"Br\u00f6ker M, Berti F, Schneider J, Vojtek I. Polysaccharide conjugate vaccine protein carriers as a \u201cneglected valency\u201d - potential and limitations. Vaccine. 2017;35(25):3286\u201394. https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.078.","journal-title":"Vaccine"},{"issue":"1","key":"1298_CR52","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4161\/hv.22302","volume":"9","author":"C Baccarini","year":"2013","unstructured":"Baccarini C, Ternouth A, Wieffer H, Vyse A. The changing epidemiology of meningococcal disease in North America 1945-2010. Hum Vaccin Immunother. 2013;9(1):162\u201371. https:\/\/doi.org\/10.4161\/hv.22302.","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"1298_CR53","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5365\/wpsar.2013.4.4.001","volume":"4","author":"P Gunaratnam","year":"2013","unstructured":"Gunaratnam P, Massey P, Durrheim D, Torvaldsen S. Invasive meningococcal disease in elderly people, New South Wales, Australia, 1993 to 2012. West Pac Surveill Response J. 2013;4(4):4\u201310. https:\/\/doi.org\/10.5365\/wpsar.2013.4.4.001.","journal-title":"West Pac Surveill Response J"},{"key":"1298_CR54","unstructured":"Parker S, Almayahi ZK. Saudi Arabia: Hajj and Umrah Pilgrimages. In: CDC Yellow Book: Health Information for International Travel. 2026 ed. Washington (DC): CDC; 2025."}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01298-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-025-01298-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01298-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T17:56:20Z","timestamp":1771696580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-025-01298-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1298"],"URL":"https:\/\/doi.org\/10.1007\/s40121-025-01298-w","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare the following financial interests\/personal relationships, which may be considered as potential competing interests: Alp Dogu is a Sanofi employee and may hold shares and\/or stock options in the company. Ghassan Dbiabo received grants from Sanofi to his institution. Ismail Balik, Irem Akdemir, Turan Buzgan, Rahmet Guner, Celina Boutros, Stephanie Damaj, Zeinab El Zein, Sarah Merhi, Kawthar Faour, Nadim Tfaily, Sarah Khafaja, and Mehmet Ceyhan report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The protocol and any amendments were approved by applicable independent ethics committees or institutional review boards at each participating site and the appropriate regulatory agencies in each country (Supplementary methods). The study was consistent with the standard established by the Declaration of Helsinki and compliant with the International Council on Harmonisation guidelines for Good Clinical Practice, including all local and\/or national regulations and directives. Signed and dated informed consent was received by all participants prior to the start of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}